• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝硬化所致门静脉高压的药物治疗]

[Medical therapy of portal hypertension due to liver cirrhosis].

作者信息

Cerini R, Sperandeo M, Varriale A, De Rosa M L, Cacciatore L

机构信息

Istituto di Medicina socio-territoriale, II Facoltà di Medicina, Università, Napoli.

出版信息

Recenti Prog Med. 1991 Feb;82(2):91-9.

PMID:2034876
Abstract

Several vasoactive agents are known to reduce portal pressure and therefore are potentially useful in the treatment of portal hypertension. These drugs act in different ways and seem to have several actions. In most cases, their exact mechanisms have not yet been elucidated and more investigations are required. Different pharmacologic treatments of portal hypertension may result from these hemodynamic studies but more trials are required in the forthcoming years.

摘要

已知几种血管活性药物可降低门静脉压力,因此在门静脉高压症的治疗中可能有用。这些药物作用方式不同,似乎有多种作用。在大多数情况下,其确切机制尚未阐明,需要更多的研究。这些血流动力学研究可能会带来门静脉高压症不同的药物治疗方法,但在未来几年还需要更多的试验。

相似文献

1
[Medical therapy of portal hypertension due to liver cirrhosis].[肝硬化所致门静脉高压的药物治疗]
Recenti Prog Med. 1991 Feb;82(2):91-9.
2
[Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].[肝硬化门静脉高压症内科治疗的病理生理基础]
Ann Ital Med Int. 1996 Oct;11 Suppl 2:39S-47S.
3
[New trends in the treatment of hemodynamic disorders in liver cirrhosis].[肝硬化血流动力学紊乱治疗的新趋势]
Klin Med (Mosk). 1991 Sep;69(9):11-4.
4
Hemodynamics in the isolated cirrhotic liver.离体肝硬化肝脏的血流动力学
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S254-8. doi: 10.1097/MCG.0b013e318150d3b5.
5
Pharmacological treatment of portal hypertension.门静脉高压症的药物治疗
Curr Opin Investig Drugs. 2001 Oct;2(10):1407-13.
6
[Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Eksp Klin Gastroenterol. 2008(5):37-41.
7
Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.针对肝硬化循环功能障碍:特利加压素与肝肾综合征
J Gastroenterol Hepatol. 2009 Nov;24(11):1707-9. doi: 10.1111/j.1440-1746.2009.06034.x.
8
Pulmonary complications in cirrhosis.肝硬化的肺部并发症。
Curr Opin Organ Transplant. 2011 Jun;16(3):281-8. doi: 10.1097/MOT.0b013e32834664df.
9
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.辛伐他汀降低肝硬化和门静脉高压患者的门静脉压力:一项随机对照试验。
Gastroenterology. 2009 May;136(5):1651-8. doi: 10.1053/j.gastro.2009.01.043. Epub 2009 Jan 24.
10
Beta-blockers and portal hypertension, hemodynamic effects and prevention of recurrent gastrointestinal bleeding.β受体阻滞剂与门静脉高压、血流动力学效应及复发性胃肠道出血的预防
Hepatogastroenterology. 1990 Dec;37(6):556-60.